The administration of intravenous fat emulsions (IVFE) is an essential component of parenteral nutrition (PN) regimes for pediatric and adult patients. IVFEs are formulated to provide essential fatty acids and a dense source of calories to help reduce the volume required for PN. The majority of IVFE’s available are made up of long-chain triglycerides (LCT) including soybean oil (omega-6), olive oil (omega-9), fish oil (omega-3) and medium-chain triglycerides (MCT). Undiluted, these IVFEs can be given separately from the PN admixtures or added to the PN for an “all-in-one” (AIO) admixture.
Whether administering AIOs or IVFEs, both methods are prone to precipitation, meaning that large particulates (e.g., enlarged lipid droplets) have the potential to enter the body, leading to patient injury. Special populations such as the critically ill, neonatal and pediatric patients are at a higher risk due to their co-morbidities and size, and serious injuries up to and including death can occur.